Andelyn Biosciences, Inc., a cell and gene therapy CDMO, has been selected by Hubble Therapeutics to manufacture adeno-associated virus (AAV) using its suspension AAV Curator Platform to manufacture clinical grade AAV for the treatment of Leber Congenital Amaurosis 16 (LCA16)   LCA16 is a severe, early-onset retinal dystrophy resulting from mutations in the KCNJ13 gene, which expresses a critical ion channel in the retinal pigment epithelium cells in the retina. Children typically present with...